Did you know?

ChinaBio^® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

Free Report

State of China Life Science 2022

Free Content

Week in Review

In My Opinion

Free Articles

Subscriber Content

AstraZeneca, Wuxi City Partner to Open New China Life Science Park

publication date: Sep 9, 2019

Supported by AstraZeneca and the Wuxi municipal government, the Wuxi International Life Science Innovation Campus has officially opened in the Wuxi High-tech District. Over the next three years, the new park expects to eventually provide space for 50 innovative life science companies. AstraZeneca will collaborate with the park's resident companies, using its global R&D network to accelerate innovation. The park aims to build a healthcare ecosystem that develops innovative products for China and global markets. More details....

Stock Symbol: (NYSE: AZN)

Share this with colleagues:

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Click here to join.